Showing results (1801-1810 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|April 11, 2013
Pharmacogenomics of bipolar disorderGiovanni Severino, Alessio Squassina, Marta Costa, et al.Pharmacogenomics|May 9, 2013
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.Pharmacogenomics|May 9, 2013
Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patientsAndré Bp van Kuilenburg, Jan Gerard MaringPharmacogenomics|February 12, 2013
Company profile: Aviir, IncMichael Beggs, William H Biggs, Cynthia FrenchPharmacogenomics|February 12, 2013
Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variantsLazara Karelia Montané Jaime, Anthony Lalla, Werner Steimer, et al.Pharmacogenomics|February 12, 2013
Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant responseMengjia Pu, Zhijun Zhang, Zhi Xu, et al.Pharmacogenomics|February 12, 2013
NAT2 sequence polymorphisms and acetylation profiles in IndiansNaazneen Khan, Veena Pande, Aparup DasPharmacogenomics|February 27, 2013
Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traitsMichael J WagnerPharmacogenomics|February 27, 2013
Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicineMaša Umićević Mirkov, Marieke J H CoenenPharmacogenomics|December 21, 2012
Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemiaMiao Hu, Valiant Wl Mak, Yajie Xiao, et al.Pageof 276